Catalyst Pharmaceuticals (CPRX)

Data from SEC filings
Employee count
CEO pay ratio
CEO Salary
Median Employee Salary
Shareholder alignment
Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM
On December 3, 2021, the Company held its 2021 Annual Meeting of Stockholders. The final voting results on the matters considered at the meeting were as follows:
1. Election of Directors:

NameVotes ForVotes AgainstVotes AbstainedBroker Non-Votes
Patrick J. McEnany59,574,2973,080,363117,84713,671,975
Philip H. Coelho55,744,7336,915,068112,70613,671,975
Charles B. O’Keeffe57,495,4455,166,109110,95313,671,975
David S. Tierney57,290,9275,331,612149,96813,671,975
Donald A. Denkhaus58,881,0123,779,909111,58613,671,975
Richard J. Daly52,925,6479,734,474112,38613,671,975
Molly Harper60,787,8561,805,179179,47213,671,975
2. Approval of an amendment to the Company’s 2018 Stock Incentive Plan increasing the number of shares authorized under the plan by 5,000,000 shares (from 10,000,000 shares to 15,000,000 shares):

Votes ForVotes AgainstVotes AbstainedBroker Non-Votes
3. Approval, on an advisory basis, of 2020 compensation of our named executive officers

Votes ForVotes AgainstVotes AbstainedBroker Non-Votes


4. Ratification of the selection of Grant Thornton, LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2021:

Votes ForVotes AgainstVotes Abstained